Medicamen Biotech (BOM:531146) YoY EBITDA Growth : 19.46% (As of Dec. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Medicamen Biotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Medicamen Biotech's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was 19.46%.

Medicamen Biotech's EBITDA per Share for the three months ended in Dec. 2024 was ₹5.39.

Medicamen Biotech YoY EBITDA Growth Historical Data

The historical data trend for Medicamen Biotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicamen Biotech YoY EBITDA Growth Chart

Medicamen Biotech Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

YoY EBITDA Growth

Get a 7-Day Free Trial

-1.97

-5.62

26.48

0.65

-6.77

Medicamen Biotech Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															-12.27	-8.05	-45.27	9.76	19.46

Medicamen Biotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Medicamen Biotech's YoY EBITDA Growth for the fiscal year that ended in Mar. 2024 is calculated as:

	YoY EBITDA Growth (A: Mar. 2024 )
=	(EBITDA per Share (A: Mar. 2024 )	-	EBITDA per Share (A: Mar. 2023 ))	/	\| EBITDA per Share (A: Mar. 2023 ) \|
=	(19.406	-	20.816)	/	\| 20.816 \|
=	-6.77 %

Medicamen Biotech's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(5.389	-	4.511)	/	\| 4.511 \|
=	19.46 %

Medicamen Biotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Medicamen Biotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Medicamen Biotech Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicamen Biotech Ltd (BOM:531146) » Definitions » YoY EBITDA Growth

Traded in Other Exchanges

MEDICAMEQ:India

Address

1506, Chiranjiv Tower, 43, Nehru Place, New Delhi, IND, 110019

Website

https://www.medicamen.com

Medicamen Biotech Ltd is an Indian based pharmaceutical company. The company is engaged in developing and manufacturing Pharmaceuticals formulations products. It manufactures Tablets, Capsules, Oral liquids, Dry syrups, Ointments, and Oral rehydration solution. The company generates revenue from the sale of pharmaceutical products.

Medicamen Biotech Headlines

No Headlines